Dr. Lee M. Zehngebot, MD
- Medicare services, 2018
- 41,976
- Part D claims, 2018
- 460
- Clinical trials
- 9
- Industry payments
- $40,036
- Affiliated sites
- 2
- Practice address
- 2501 N Orange Ave, Orlando, FL 32804-4623
- Practice phone
- Call (407) 898-5452
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Florida Cancer Specialists
Medical specialty practice · Orlando, Florida
Find Dr. Zehngebot's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Lee M. Zehngebot is a hematologist and oncologist in Davenport, Florida
Dr. Zehngebot practices at Florida Cancer Specialists in Orlando, Florida.
Dr. Zehngebot's NPI, 1588622419, was assigned on May 2, 2006. Dr. Zehngebot holds Florida license ME0046635.
- NPI
- 1588622419NPI Registry (opens in a new tab)
- NPI enumeration date
- May 2, 2006
- NPI status
- Active
- Practice phone
- (407) 898-5452
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Lee M. Zehngebot practices in Orlando and Davenport
Dr. Zehngebot's primary practice is Florida Cancer Specialists, at 2501 N Orange Ave, Orlando, FL 32804-4623. The practice phone is (407) 898-5452. The NPI Registry lists Dr. Zehngebot's practice address as 40100 Hwy 27, Davenport, FL 33837.
- Florida Cancer SpecialistsPrimary2501 N Orange Ave, Orlando, FL 32804-4623Phone(407) 898-5452
- NPI Registry address40100 Hwy 27, Davenport, FL 33837 · Polk CountyPhone(407) 898-5452
Sources: NPPES NPI Registry (CMS); Dmand AI Affiliation Data; Doctors and Clinicians National Downloadable File (CMS); and Dmand AI Practice Data
Dr. Lee M. Zehngebot is affiliated with 2 sites of care and 3 medical groups
Dr. Zehngebot's primary practice is Florida Cancer Specialists in Orlando, Florida. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Dr. Zehngebot to 2 more medical groups and 1 group practice or clinic, each named with a free account.
Sources: Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dmand AI tracks the EHR system at Dr. Lee M. Zehngebot's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zehngebot practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Florida Cancer Specialists | Available with a free account |
| +1 more site and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Lee M. Zehngebot is one of 693 hematologists and oncologists in Florida
Hematology and oncology is Dr. Zehngebot's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Zehngebot is licensed in Florida.
Specialties and state licenses
- Hematology and oncology, FloridaPrimary
Hematologists and oncologists near Dr. Zehngebot
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Lee M. Zehngebot billed Medicare for 41,976 services in 2018
CMS data shows 41,976 Medicare services from Dr. Zehngebot across 50 procedure codes in 2018. Medicare paid $1,254,219 for them. Every service was in an office.
Dr. Zehngebot's Medicare services by type, 2017 to 2018
- 2017
- 2018
- Drugs given in the office
- 2017: 178,2322018: 32,73482%
- Lab and pathology
- 2017: 12,1512018: 3,76969%
- Other services
- 2017: 2,0212018: 2,0471%
- Tests and treatments
- 2017: 4,7972018: 1,29473%
- Surgery
- 2017: 3,8132018: 1,12670%
- Office and hospital visits
- 2017: 3,8572018: 1,00674%
Dr. Zehngebot compared with the Florida median for hematologists and oncologists, 2018
- Dr. Zehngebot
- Florida median
- Medicare services
- 41,976vs 69760.2 times
- Part D claims
- 460vs 34135% above
Medians across 638 hematologists and oncologists in Florida with Dmand AI profiles that report each measure.
Dr. Zehngebot's most billed Medicare procedure codes, 2018
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Zehngebot?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Zehngebot and other hematologists and oncologists in Florida.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Lee M. Zehngebot's patients have a median age of 67
Across all payers, Dmand AI patient panel data puts Dr. Zehngebot's median patient age at 67, with 39% women.
Dr. Zehngebot's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 67
Patient panel by sex, all payers
- Women39%
- Men58%
Source: Dmand AI Patient Panel Data
Dr. Lee M. Zehngebot wrote 460 Medicare Part D claims in 2018
In 2018, Dr. Zehngebot wrote 460 Medicare Part D claims. They cover 21 drugs, with $1,549,656 in total drug cost. In 2017, CMS named 1,669 claims across 50 drugs.
Dr. Zehngebot's most prescribed drugs by claims, 2018
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2017 to 2018
- 2017
- 2018
- Claims for drugs CMS names
- 2017: 1,6692018: 46072%
Drugs named by CMS: 21 in 2018, 50 in 2017.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Lee M. Zehngebot has worked on 9 clinical trials
Dmand AI links Dr. Zehngebot to 9 clinical trials, 6 of them phase 3 studies. 7 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Breast Neoplasms. ECOG-ACRIN Cancer Research Group sponsors the most, 3.
Clinical trials with Dr. Zehngebot by phase
- NonePhase 1: no trials
- 1Phase 2: 1 trial
- 6Phase 3: 6 trials
- NonePhase 4: no trials
Conditions in Dr. Zehngebot's trials
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Bronchogenic
- Breast Neoplasms
- Breast Neoplasms, Male
- Leukemia, Megakaryoblastic, Acute
Investigators on the most trials with Dr. Zehngebot
- Elward David Crawford, MD5 shared trials
- Sheetal Sumat Acharya, MD4 shared trials
- Mitchell B. Alden, DO4 shared trials
Recent clinical trials with Dr. Zehngebot
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial) (opens in a new tab)
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial) (opens in a new tab)
Comparison of Axillary Lymph Node Dissection with Axillary Radiation for Patients with Node-Positive Breast Cancer Treated with Chemotherapy (opens in a new tab)
Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer (opens in a new tab)
Sources: ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
Dr. Lee M. Zehngebot received $40,036 in industry payments from 2016 to 2018
CMS Open Payments shows 289 general payments to Dr. Zehngebot from 27 drug and device companies from 2016 to 2018. Speaker and faculty fees make up the largest share, 50% of the total. Merck Sharp & Dohme Corporation paid the most, $28,014.
General payments to Dr. Zehngebot by program year, 2016 to 2018
General payments to Dr. Zehngebot by kind, 2016 to 2018
- Speaker and faculty fees$19,93050%
- Consulting fees$12,80032%
- Food and beverage$4,61112%
- Travel and lodging$2,6627%
- Education$320%
Companies that paid Dr. Zehngebot the most, 2016 to 2018
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Lee M. Zehngebot's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Clinical trials and co-investigators | ClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Lee M. Zehngebot
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Lee M. Zehngebot's NPI number?
Dr. Lee M. Zehngebot's NPI number is 1588622419. It was assigned on May 2, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Lee M. Zehngebot?
Dr. Lee M. Zehngebot is a hematologist and oncologist in Davenport, Florida. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Lee M. Zehngebot practice?
Dr. Zehngebot practices at 2501 N Orange Ave, Orlando, FL 32804-4623. Dr. Zehngebot also practices at 40100 Hwy 27, Davenport, FL 33837. Dr. Zehngebot's primary practice is Florida Cancer Specialists in Orlando, Florida. Dmand AI also links Dr. Zehngebot to 2 medical groups and 1 group practice or clinic.
What is Dr. Lee M. Zehngebot's office phone number?
The practice phone on file for Dr. Zehngebot is (407) 898-5452.
What is Dr. Lee M. Zehngebot's medical license number?
Dr. Zehngebot holds Florida license ME0046635.
What medical group is Dr. Lee M. Zehngebot part of?
Dr. Zehngebot is linked to Florida Cancer Specialists & Research Institute. Dmand AI links Dr. Zehngebot to 2 more medical groups.
Does Dr. Lee M. Zehngebot accept Medicare?
Yes. CMS data shows Dr. Zehngebot billed Medicare for 41,976 services in 2018.
What services does Dr. Lee M. Zehngebot bill to Medicare?
In 2018, Dr. Zehngebot's most billed Medicare services were injected or infused drug (J9299), injected or infused drug (J9271) and injected or infused drug (J0885).
What drugs does Dr. Lee M. Zehngebot prescribe most?
In 2018 Medicare Part D data, Dr. Zehngebot's most prescribed drugs by claims were Anastrozole, Letrozole and Ibrance.
Has Dr. Lee M. Zehngebot received payments from drug or device companies?
CMS Open Payments shows $40,036 in general payments to Dr. Zehngebot from 27 companies from 2016 to 2018. The largest total came from Merck Sharp & Dohme Corporation.
How long has Dr. Lee M. Zehngebot been practicing?
Dr. Zehngebot's NPI was assigned in 2006.
Does Dr. Lee M. Zehngebot do research?
Dr. Zehngebot has worked on 9 clinical trials.
Selling to hematology and oncology practices?
See hematologists and oncologists in Florida by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card